DLGAP1-AS2

Across TCGA pan-cancer cohorts, DLGAP1-AS2 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated DLGAP1-AS2 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher DLGAP1-AS2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated DLGAP1-AS2 expression acts as an unfavorable survival marker, although some lineages such as READ and SKCM show a favorable association.

KIRC, ACC, and UVM are the cancer types where DLGAP1-AS2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.493	0.754	<.001	186	view →
ACC	DFS	Median	All	0.250	0.650	<.001	114	view →
UVM	DFS	Tertile	All	0.442	0.981	.001	73	view →
KICH	OS	Median	III,IV	0.468	1.000	.001	66	view →
LUAD	DFS	Tertile	All	0.707	0.827	.003	55	view →
LGG	DFS	Median	All	0.627	0.837	<.001	52	view →
READ	OS	Tertile	II,III,IV	0.873	0.320	<.001	50	view →
LIHC	OS	Median	All	0.703	0.855	<.001	37	view →
THCA	DFS	Quartile	II,III,IV	0.656	1.000	.001	30	view →
SKCM	OS	Tertile	II,III,IV	0.953	0.772	.004	20	view →
OV	OS	Tertile	II,III,IV	0.761	0.660	.018	20	view →
UCS	DFS	Quartile	II,III,IV	0.717	0.265	.006	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

DLGAP1-AS2–KIRC (OS)

Open the KIRC breakdown →